Caplin Point Laboratories Limited (CAPLIPOINT.NS)

INR 2396.95

(0.02%)

Total Debt Summary of Caplin Point Laboratories Limited

  • Caplin Point Laboratories Limited's latest annual total debt in 2023 was 19.7 Million INR , down -62.12% from previous year.
  • Caplin Point Laboratories Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Caplin Point Laboratories Limited reported annual total debt of 52 Million INR in 2022, up 144.13% from previous year.
  • Caplin Point Laboratories Limited reported annual total debt of 21.3 Million INR in 2021, down -88.42% from previous year.
  • Caplin Point Laboratories Limited reported quarterly total debt of - INR for 2023 Q3, down -100.0% from previous quarter.
  • Caplin Point Laboratories Limited reported quarterly total debt of 19.7 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Caplin Point Laboratories Limited (2023 - 2007)

Historical Annual Total Debt of Caplin Point Laboratories Limited (2023 - 2007)

Year Total Debt Total Debt Growth
2023 19.7 Million INR -62.12%
2022 52 Million INR 144.13%
2021 21.3 Million INR -88.42%
2020 183.92 Million INR -52.37%
2019 386.11 Million INR 7034.33%
2018 5.41 Million INR 0.88%
2017 5.36 Million INR -25.86%
2016 7.23 Million INR -63.89%
2015 20.03 Million INR 115.46%
2014 9.29 Million INR -56.18%
2013 21.21 Million INR -40.01%
2012 35.37 Million INR -47.64%
2011 67.55 Million INR -30.62%
2010 97.37 Million INR -6.11%
2009 103.7 Million INR 21.06%
2008 85.66 Million INR -21.85%
2007 109.61 Million INR 0.0%

Peer Total Debt Comparison of Caplin Point Laboratories Limited

Name Total Debt Total Debt Difference
Sigachi Industries Limited 1.43 Billion INR 98.623%
Ind-Swift Limited 10.13 Billion INR 99.806%
Bajaj HealthCare Limited 3.32 Billion INR 99.408%
Sakar Healthcare Limited 793.51 Million INR 97.517%
Aurobindo Pharma Limited 66.47 Billion INR 99.97%
Innova Captab Limited 2.45 Billion INR 99.196%
Divi's Laboratories Limited 30 Million INR 34.333%
AstraZeneca Pharma India Limited 45.98 Million INR 57.157%
Morepen Laboratories Limited 289.99 Million INR 93.207%
Mankind Pharma Limited 2.07 Billion INR 99.049%
Sequent Scientific Limited 4.87 Billion INR 99.596%
Wanbury Limited 1.16 Billion INR 98.309%
Laurus Labs Limited 25.77 Billion INR 99.924%
Nectar Lifesciences Limited 6.35 Billion INR 99.69%
Glenmark Life Sciences Limited 171.48 Million INR 88.512%
Alembic Limited 91.5 Million INR 78.47%
Hikal Limited 8.17 Billion INR 99.759%
Alembic Pharmaceuticals Limited 5.13 Billion INR 99.616%
Neuland Laboratories Limited 953.89 Million INR 97.935%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 99.478%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 99.84%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 93.987%
Themis Medicare Limited 957.92 Million INR 97.943%
RPG Life Sciences Limited - INR -Infinity%
Zydus Lifesciences Limited 8.04 Billion INR 99.755%
Lupin Limited 29.21 Billion INR 99.933%
Amrutanjan Health Care Limited 17.28 Million INR -13.985%
Wockhardt Limited 23.56 Billion INR 99.916%
Vaishali Pharma Limited 134.91 Million INR 85.399%
Aarti Pharmalabs Limited 2.85 Billion INR 99.309%
Jagsonpal Pharmaceuticals Limited 89.41 Million INR 77.967%
Jubilant Pharmova Limited 36.64 Billion INR 99.946%
FDC Limited 205.18 Million INR 90.399%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 99.902%
Kilitch Drugs (India) Limited 316.46 Million INR 93.775%
Eris Lifesciences Limited 27.81 Billion INR 99.929%
Venus Remedies Limited 413.3 Million INR 95.233%
ZIM Laboratories Limited 1.08 Billion INR 98.19%
Bliss GVS Pharma Limited 998.4 Million INR 98.027%
Par Drugs and Chemicals Limited - INR -Infinity%
Shilpa Medicare Limited 9.37 Billion INR 99.79%
Albert David Limited 33.24 Million INR 40.738%
Ajanta Pharma Limited 352.8 Million INR 94.416%
Hester Biosciences Limited 2.44 Billion INR 99.194%
Suven Pharmaceuticals Limited 649.96 Million INR 96.969%
Solara Active Pharma Sciences Limited 10.11 Billion INR 99.805%
Gufic Biosciences Limited 3.32 Billion INR 99.408%
Windlas Biotech Limited 36.41 Million INR 45.894%
Procter & Gamble Health Limited 95.6 Million INR 79.393%
Aarey Drugs & Pharmaceuticals Limited 313.52 Million INR 93.717%
Mangalam Drugs & Organics Limited 984.92 Million INR 98.0%
Granules India Limited 13.15 Billion INR 99.85%
Aarti Drugs Limited 5.64 Billion INR 99.651%
Bal Pharma Limited 1.39 Billion INR 98.589%
Alkem Laboratories Limited 14.18 Billion INR 99.861%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.94%
Lincoln Pharmaceuticals Limited 10.66 Million INR -84.664%
Medicamen Biotech Limited 308.17 Million INR 93.607%
Unichem Laboratories Limited 2.47 Billion INR 99.204%
Bafna Pharmaceuticals Limited 243.89 Million INR 91.923%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -348.849%
Valiant Laboratories Limited 767.08 Million INR 97.432%
Orchid Pharma Limited 1.35 Billion INR 98.543%
Medico Remedies Limited 80.5 Million INR 75.529%
Ind-Swift Laboratories Limited 166.21 Million INR 88.148%
Ipca Laboratories Limited 14.38 Billion INR 99.863%
Brooks Laboratories Limited 56.41 Million INR 65.083%
Syncom Formulations (India) Limited 724.86 Million INR 97.282%
Piramal Enterprises Limited 535.85 Billion INR 99.996%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.951%
NATCO Pharma Limited 3.71 Billion INR 99.469%
Suven Life Sciences Limited 7.09 Million INR -177.582%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 98.982%
Strides Pharma Science Limited 25.16 Billion INR 99.922%
Indoco Remedies Limited 6.71 Billion INR 99.707%
Alpa Laboratories Limited 52.46 Million INR 62.451%
Lasa Supergenerics Limited 220.76 Million INR 91.076%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 96.778%